These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
686 related articles for article (PubMed ID: 27581198)
1. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery. Lindahl A; Forshed J; Nordström A Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198 [TBL] [Abstract][Full Text] [Related]
2. Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Khamis MM; Adamko DJ; El-Aneed A Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008 [TBL] [Abstract][Full Text] [Related]
3. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Xu W; Chen D; Wang N; Zhang T; Zhou R; Huan T; Lu Y; Su X; Xie Q; Li L; Li L Anal Chem; 2015 Jan; 87(2):829-36. PubMed ID: 25486321 [TBL] [Abstract][Full Text] [Related]
4. Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Li Y; Song X; Zhao X; Zou L; Xu G J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 966():147-53. PubMed ID: 24856296 [TBL] [Abstract][Full Text] [Related]
5. Metabolic profiles in community-acquired pneumonia: developing assessment tools for disease severity. Ning P; Zheng Y; Luo Q; Liu X; Kang Y; Zhang Y; Zhang R; Xu Y; Yang D; Xi W; Wang K; Chen Y; An S; Gao Z Crit Care; 2018 May; 22(1):130. PubMed ID: 29759075 [TBL] [Abstract][Full Text] [Related]
6. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery. Peng J; Chen YT; Chen CL; Li L Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652 [TBL] [Abstract][Full Text] [Related]
7. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry. Wu N; Wang W; Yi M; Cheng S; Wang D Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383 [TBL] [Abstract][Full Text] [Related]
8. LC/MS-based polar metabolite profiling reveals gender differences in serum from patients with myocardial infarction. Lee J; Jung Y; Park JY; Lee SH; Ryu DH; Hwang GS J Pharm Biomed Anal; 2015 Nov; 115():475-86. PubMed ID: 26299524 [TBL] [Abstract][Full Text] [Related]
9. Global metabolic profiling using ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry. Qi Y; Song Y; Gu H; Fan G; Chai Y Methods Mol Biol; 2014; 1198():15-27. PubMed ID: 25270920 [TBL] [Abstract][Full Text] [Related]
10. Metabolic Disturbances in Adult-Onset Still's Disease Evaluated Using Liquid Chromatography/Mass Spectrometry-Based Metabolomic Analysis. Chen DY; Chen YM; Chien HJ; Lin CC; Hsieh CW; Chen HH; Hung WT; Lai CC PLoS One; 2016; 11(12):e0168147. PubMed ID: 28005947 [TBL] [Abstract][Full Text] [Related]
11. Application of LC-MS-based metabolomics method in differentiating septic survivors from non-survivors. Liu Z; Yin P; Amathieu R; Savarin P; Xu G Anal Bioanal Chem; 2016 Nov; 408(27):7641-7649. PubMed ID: 27614981 [TBL] [Abstract][Full Text] [Related]
12. Metabolite variations between acute-on-chronic liver failure and chronic liver failure caused by hepatitis B virus based on ultra-performance liquid chromatography mass spectrometry. Lian J; Li X; Wang Y; Yang J; Liu W; Ma J; Chen D; Li L; Huang J Biomed Pharmacother; 2016 Dec; 84():994-1000. PubMed ID: 27768929 [TBL] [Abstract][Full Text] [Related]
13. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling. Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054 [TBL] [Abstract][Full Text] [Related]
14. LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis. Li J; Che N; Xu L; Zhang Q; Wang Q; Tan W; Zhang M Clin Rheumatol; 2018 Jun; 37(6):1493-1502. PubMed ID: 29442259 [TBL] [Abstract][Full Text] [Related]
15. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics. Shen W; Han W; Li Y; Meng Z; Cai L; Li L Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112 [TBL] [Abstract][Full Text] [Related]
16. High-throughput ultra-performance liquid chromatography-mass spectrometry characterization of metabolites guided by a bioinformatics program. Zhang AH; Wang P; Sun H; Yan GL; Han Y; Wang XJ Mol Biosyst; 2013 Sep; 9(9):2259-65. PubMed ID: 23821129 [TBL] [Abstract][Full Text] [Related]
17. Joint MS-based platforms for comprehensive comparison of rat plasma and serum metabolic profiling. Lin Z; Zhang Z; Lu H; Jin Y; Yi L; Liang Y Biomed Chromatogr; 2014 Sep; 28(9):1235-45. PubMed ID: 24619916 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of serum metabolites in gestational diabetes mellitus by UPLC/Q-TOF-MS. Liu T; Li J; Xu F; Wang M; Ding S; Xu H; Dong F Anal Bioanal Chem; 2016 Feb; 408(4):1125-35. PubMed ID: 26677023 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive metabolic profiling of Parkinson's disease by liquid chromatography-mass spectrometry. Shao Y; Li T; Liu Z; Wang X; Xu X; Li S; Xu G; Le W Mol Neurodegener; 2021 Jan; 16(1):4. PubMed ID: 33485385 [TBL] [Abstract][Full Text] [Related]